Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (51-60 of 149) with videos related to

Pageof 15
Sort By:
Plos One|July 16, 2011
High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assaysRoland Houben, Sonja Hesbacher, Corinna P Schmid, et al.
Frontiers in Oncology|July 6, 2019
Potential Use of Gluconate in Cancer TherapyMaria E Mycielska, Markus T J Mohr, Katharina Schmidt, et al.
The Journal of Investigative Dermatology|April 20, 2012
Absence of distinguishing senescence traits in human melanocytic neviSieu L Tran, Sebastian Haferkamp, Lyndee L Scurr, et al.
Frontiers in Cell and Developmental Biology|January 11, 2021
Extracellular Citrate Fuels Cancer Cell Metabolism and GrowthSebastian Haferkamp, Konstantin Drexler, Marianne Federlin, et al.
International Journal of Molecular Sciences|October 20, 2020
SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell LineSabine Stöckl, Georg Lindner, Shushan Li, et al.
Nature Communications|June 26, 2024
Restricting datasets to classifiable samples augments discovery of immune disease biomarkersGunther Glehr, Paloma Riquelme, Katharina Kronenberg, et al.
Journal of Medical Case Reports|May 18, 2024
Fistulising skin metastases in Crohn's disease: a case report and review of the literatureTanja Elger, Johanna Loibl, Christa Buechler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Head & Face Medicine|October 23, 2021
Head and neck melanoma: outcome and predictors in a population-based cohort studySteffen Spoerl, Gerrit Spanier, Elena Reiter, et al.
Frontiers in Immunology|December 6, 2021
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related ComplicationsHannah-Lou Schilling, Gunther Glehr, Michael Kapinsky, et al.
Pageof 15

Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Plos One|July 16, 2011
High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assaysRoland Houben, Sonja Hesbacher, Corinna P Schmid, et al.
Frontiers in Oncology|July 6, 2019
Potential Use of Gluconate in Cancer TherapyMaria E Mycielska, Markus T J Mohr, Katharina Schmidt, et al.
The Journal of Investigative Dermatology|April 20, 2012
Absence of distinguishing senescence traits in human melanocytic neviSieu L Tran, Sebastian Haferkamp, Lyndee L Scurr, et al.
Frontiers in Cell and Developmental Biology|January 11, 2021
Extracellular Citrate Fuels Cancer Cell Metabolism and GrowthSebastian Haferkamp, Konstantin Drexler, Marianne Federlin, et al.
International Journal of Molecular Sciences|October 20, 2020
SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell LineSabine Stöckl, Georg Lindner, Shushan Li, et al.
Nature Communications|June 26, 2024
Restricting datasets to classifiable samples augments discovery of immune disease biomarkersGunther Glehr, Paloma Riquelme, Katharina Kronenberg, et al.
Journal of Medical Case Reports|May 18, 2024
Fistulising skin metastases in Crohn's disease: a case report and review of the literatureTanja Elger, Johanna Loibl, Christa Buechler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Head & Face Medicine|October 23, 2021
Head and neck melanoma: outcome and predictors in a population-based cohort studySteffen Spoerl, Gerrit Spanier, Elena Reiter, et al.
Frontiers in Immunology|December 6, 2021
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related ComplicationsHannah-Lou Schilling, Gunther Glehr, Michael Kapinsky, et al.
Pageof 15